Navigation Links
Isis Reports Reduction of apoB-100 Levels in a Murine Model Resulting in Up to 92% Reduction of Atherosclerosis
Date:4/18/2008

CARLSBAD, Calif., April 18 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) presented the results of two studies designed to assess the impact of lowering apoB-100 on atherosclerosis at the 2008 Annual Atherosclerosis, Thrombosis and Vascular Biology (ATVB) Conference in Atlanta, Georgia. The data were presented in a poster entitled "Antisense Inhibition of Apolipoprotein B Ameliorated Diet-Induced Hypercholesterolemia and Reduced Atherosclerosis in LDL Receptor-Deficient Mice" by Adam E. Mullick, Ph.D. of Isis yesterday at ATVB.

Both studies were performed in a murine model in which the LDL receptor, which is responsible for the maintenance of normal serum cholesterol levels, has been genetically eliminated. These animals have very high cholesterol levels (1,000 - 2,000 mg/dL on a high fat diet) and develop severe atherosclerosis. In the first study, the impact of treatment with an antisense drug was evaluated in the context of two atherogenic high fat diets. Animals on these diets had elevated total cholesterol and LDL-cholesterol levels that increased during the two weeks of high fat diet prior to drug treatment. These cholesterol levels dramatically decreased during the 10 week treatment period. At a dose of 50 mg/kg twice weekly, the murine apoB-100 antisense drug reduced total cholesterol and LDL-cholesterol by 87% and 93%, respectively. These reductions in cholesterol directly correlated with reduction in liver and plasma apoB-100 levels. Aortic atherosclerotic lesions were reduced by 78% - 92% in the same animals.

The second study, which evaluated the effects of increasing doses of drug on lipid levels, confirms and extends the results of the previous study, and showed that the effects of the apoB-
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Sunesis Pharmaceuticals Reports Data from Nonclinical Studies of SNS-032 at the Annual Meeting of the American Association for Cancer Research
2. Novavax Reports Positive Results from Preclinical Studies of its VLP-based Trivalent Seasonal Influenza Vaccine Candidate
3. Pharmacyclics Reports Multiple Presentations at AACR on Its HDAC and Selective HDAC Inhibitors
4. Medarex Reports Interim Data from Ongoing Ipilimumab Combination Phase 1 Studies in Prostate Cancer at American Association for Cancer Research Meeting
5. NOLabs AB Reports Success in Fight Against Bacteria Causing Urinary Tract Infection
6. Enanta Reports New Macrolide-Related Drug Class, Bicyclolides, to Combat Hospital and Community Acquired Superbug Infections, Including MRSA
7. MAP Pharmaceuticals Reports Positive Results From Phase 2a Clinical Trial of Combination Therapy in Adult Asthmatics
8. Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2007 Financial Results
9. Rexinoid Developed by NuRx Pharmaceuticals Shows Promise in Prevention, Treatment of Lung, Breast Cancer, Paper in Clinical Cancer Research Reports
10. MAP Pharmaceuticals Reports Positive Results From Comparative Pharmacokinetic Trial for its Pediatric Asthma Product Candidate
11. New Study Reports That Physical Therapy Treatment Resolves Symptoms of Urinary Incontinence in Women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... N.J. , May 23, 2013 Nephros, ... commercial stage medical device company that develops and sells ... completion of its rights offering.  In addition, the concurrent ... 2011 warrants expired on May 17, 2013. ... $3.0 million from the rights offering.   A portion of ...
(Date:5/23/2013)... , May 23, 2013  A recently published clinical ... Houston, Texas , demonstrates that 3D mammography ... cancer detection. The study, "Implementation of ... Study," was led by Stephen L. Rose ... of the American Journal of Roentgenology (AJR). ...
(Date:5/23/2013)... , May 23, 2013 More than ... may not benefit from chemotherapy and still have excellent ... launch of one of the largest sources of online ... website and interactive Facebook page provide recently diagnosed women ... can safely avoid chemotherapy. "We anticipate these ...
Breaking Medicine Technology:Nephros Announces Completion of Rights Offering 2Nephros Announces Completion of Rights Offering 3Nephros Announces Completion of Rights Offering 4First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 2First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 3Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 2Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 3
... Reportlinker.com announces that a new market research report is available in its catalogue: , ... European Markets for Gastrointestinal Endoscopic Devices 2010 ... http://www.reportlinker.com/p0196554/European-Markets-for-Gastrointestinal-Endoscopic-Devices-2010-15-Countries.html ... The European market for gastrointestinal endoscopic devices was ...
... July 6 E. Fougera & Co., a leading ... from the FDA for Adapalene Cream 0.1% (Rx).  Fougera,s Adapalene ... Galderma Pharmaceuticals. According to industry data, U.S. sales of the ... This approval also marks the fourth product approval that the ...
Cached Medicine Technology:Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) 2Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) 3Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) 4Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) 5Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) 6Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) 7Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) 8Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) 9Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) 10Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) 11Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) 12Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) 13Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) 14Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) 15Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) 16Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) 17Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) 18Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) 19Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) 20Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) 21Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) 22Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) 23Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) 24Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) 25Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) 26Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) 27Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) 28Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) 29Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) 30Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) 31Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) 32Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) 33Fougera® Announces First Generic Approval of Adapalene Cream 0.1% (Rx), Equivalent to Differin® 2Fougera® Announces First Generic Approval of Adapalene Cream 0.1% (Rx), Equivalent to Differin® 3
(Date:5/25/2013)... May 25, 2013 Radius Engineering ... shelter company in the US and has been ... for over 35 years. M.E. and President, Walton ... of NBC Weapon Fundamentals and Shelter Engineering Standards, ... bible on shelter engineering. McCarthy is considered the ...
(Date:5/25/2013)... On May 20, 2013 the Sydney ... to discuss or plan for their eventual demise, but it ... released a Must-Do List to help people properly arrange for ... a personal fact sheet.” , While not a formal document, ... personal data. It may include a summary of assets, ...
(Date:5/25/2013)... May 25, 2013 On May 25, ... cancer research and advocacy, comments on a new study ... shows incorporating cold atmospheric plasma into brain cancer treatment ... According to a Science Daily article, physicists ... biologists and physicians demonstrated the “synergistic effect of cold ...
(Date:5/25/2013)... 25, 2013 According to world-renowned scholars, ... and powerful women that ever lived. Cleopatra’s legendary beauty ... of the most powerful men in her time. Cleopatra ... to keep her skin glowing and fresh, from her ... wax, maringa oil and cyprus grass. , Cleopatra was ...
(Date:5/25/2013)... Bradley, Illinois (PRWEB) May 25, 2013 ... assisted living community, is hosting an American Red Cross ... May 30. , The community, which is located at ... of all incomes, including those on Medicaid, who need ... give the Gift of Life," says Andrea Arview Frey, ...
Breaking Medicine News(10 mins):Health News:Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster 2Health News:Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster 3Health News:FuneralFinancials.com Releases Last Wishes Must-Do List 2Health News:Voices Against Brain Cancer Comments on Study that Shows Cold Plasma’s Success Against Brain Cancer Cells 2Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 2Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 3Health News:Carbondale Affordable Assisted Living Community to Host Red Cross Blood Drive 2
... SHANGHAI , Feb. 12 General Nutrition Centers, ... today that it, together with its parent company, has entered into ... Food (Group) Co., LTD (Bright Food). The partnership, to be named ... Bright Food , a leading state-owned conglomerate in China ...
... obesity and high-risk pregnancies caused by preeclampsia and diabetes ... Institutes of Health research grant received by Sean Blackwell, ... and Reproductive Sciences at The University of Texas Medical ... will provide them with a better understanding of the ...
... who received male donors, plasma had worse outcomes, study ... U.S. blood-banking industry discourages transfusing the blood product known ... dangerous reaction in the recipients. , But now researchers ... actually have advantages. , Plasma is the fluid ...
... Deaths totaled over 17,000, still fewer than ,typical, flu season ... swine flu pandemic apparently winding down, federal health officials said ... illness since last April, and the total could range as ... for Disease Control and Prevention (CDC) estimates that as many ...
... in humans, research shows , FRIDAY, Feb. 12 (HealthDay News) -- ... on the balls of your feet or on your toes, a ... 83 percent more energy to walk on your toes and 53 ... according to the University of Utah researchers. They measured energy expenditure ...
... others boosts attractiveness , FRIDAY, Feb. 12 (HealthDay News) ... with? New research suggests you,ll gain extra points ... others in activities like volunteering. , When it comes ... author Pat Barclay, an assistant professor at the University ...
Cached Medicine News:Health News:GNC Announces Entry to China's Nutritional Products in Partnership with Bright Food 2Health News:GNC Announces Entry to China's Nutritional Products in Partnership with Bright Food 3Health News:GNC Announces Entry to China's Nutritional Products in Partnership with Bright Food 4Health News:UT researcher receives $2.4 million to research obesity, high-risk pregnancy 2Health News:Restrictions on Plasma From Female Donors May Need Revisiting 2Health News:57 Million Americans Sickened by H1N1 Flu: CDC 2Health News:57 Million Americans Sickened by H1N1 Flu: CDC 3Health News:Heel-First Walking Conserves Energy 2Health News:Want to Find Love? Be Giving 2Health News:Want to Find Love? Be Giving 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: